Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1390777 NEW YORK, NY
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,346,768
+$29,336 QoQ
Shares Held
168,136
+2.5% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 208 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. SPRY ranks #179 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in SPRY

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,346,768 168,136
2026-03-31 $1,317,432 164,064
2025-12-31 $1,899,018 163,006
2025-09-30 $1,553,769 154,604
2025-06-30 $2,532,290 145,117
2025-03-31 $1,663,238 132,213
2024-12-31 $1,374,009 130,238
2024-09-30 $1,908,358 131,611
2024-06-30 $1,185,315 139,285
2024-03-31 $714,284 69,891
2023-12-31 $462,281 84,358
2023-09-30 $317,232 83,924
2023-06-30 $515,229 76,900
2023-03-31 $98,853 15,185
2022-12-31 $129,527 15,185
2022-03-31 $205,839 58,644
2021-12-31 $400,005 60,061
2021-09-30 $565,545 56,668
2021-06-30 $1,221,514 39,544
2021-03-31 $1,518,846 34,812